Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 8/20 | 1.00 |
| ▸ | CA9 | Q16790 | 8/20 | 1.00 |
| ▸ | CA1 | P00915 | 6/20 | 1.00 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | CA2 | P00918 | 3/20 | 0.56 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.56 |
| ▸ | POLB | P06746 | 2/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.55 |
| ▸ | GLA | P06280 | 1/20 | 0.53 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7829007 | 0.89 | CA12 (0.80) | CA12CA9CA1DDAH1ALDH1A1 | |
| SCHEMBL12261669 | 0.82 | CA12 (0.70) | CA12CA9CA1ALDH1A1CA2 | |
| SCHEMBL7287582 | 0.82 | CA12 (0.68) | CA12CA9CA1DDAH1ALDH1A1 | |
| SCHEMBL15741868 | 0.82 | CA12 (0.68) | CA12CA9CA1DDAH1ALDH1A1 | |
| SCHEMBL11478927 | 0.82 | CA12 (0.67) | CA12CA9CA1ALDH1A1CA2 | |
| SCHEMBL27893066 | 0.82 | CA12 (0.69) | CA12CA9CA1ALDH1A1CA2 | |
| SCHEMBL368155 | 0.82 | CA12 (0.69) | CA12CA9CA1ALDH1A1CA2 | |
| Hydrochloric Acid SCHEMBL7288973 | 0.81 | CA12 (0.66) | CA12CA9CA1DDAH1ALDH1A1 | |
| SCHEMBL8058716 | 0.80 | CA12 (0.67) | CA12CA9CA1ALDH1A1CA2 | |
| SCHEMBL11020613 | 0.79 | CA12 (0.65) | CA12CA9CA1DDAH1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102964598-A | Polymaleimide polymer as well as preparation method and application of polymaleimide polymer | CAS GUANGZHOU CHEMISTRY CO LTD | 2013-03-13 | — | — | CN | claimed |
| US-20250326731-A1 | CATALYST-CONTROLLED SITE-SELECTIVE METHYLENE C-H LACTONIZATION OF DICARBOXYLIC ACIDS | SCRIPPS RESEARCH INST (US) | 2025-10-23 | — | — | US | disclosed |
| CN-116023951-A | Liquid crystal aligning agent, liquid crystal alignment film, method for producing the same, liquid crystal element, and polymer | JSR株式会社 | 2023-04-28 | — | — | CN | disclosed |
| CN-114479880-A | Liquid crystal aligning agent, liquid crystal alignment film, method for producing liquid crystal alignment film, liquid crystal element, and method for producing liquid crystal element | JSR株式会社 | 2022-05-13 | — | — | CN | disclosed |
| CN-114381281-A | Liquid crystal aligning agent, liquid crystal alignment film, liquid crystal element, method for producing liquid crystal element, and compound | JSR株式会社 | 2022-04-22 | — | — | CN | disclosed |
| CN-108329336-B | Metal complex of dicapryl [4] arene derivative and synthetic method and application thereof | 中国科学院苏州生物医学工程技术研究所 | 2020-06-05 | — | — | CN | disclosed |
| WO-2020039695-A1 | LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, LIQUID CRYSTAL ELEMENT, AND LIQUID CRYSTAL ELEMENT MANUFACTURING METHOD | JSR株式会社 | 2020-02-27 | — | — | WO | disclosed |
| CN-108586502-B | Metal complex of dicapryl [4] arene derivative and synthetic method and application thereof | 中国科学院苏州生物医学工程技术研究所 | 2019-12-27 | — | — | CN | disclosed |
| CN-108395372-B | The metal complex and its synthetic method of double cup [4] arene derivatives and application | 中国科学院苏州生物医学工程技术研究所 | 2019-09-10 | — | — | CN | disclosed |
| CN-108314690-B | The metal complex and its synthetic method of double cup [4] arene derivatives and application | 中国科学院苏州生物医学工程技术研究所 | 2019-06-07 | — | — | CN | disclosed |
| US-8362004-B2 | Piperazine analogs as broad-spectrum influenza antivirals | BRISTOL-MYERS SQUIBB COMPANY (US) | 2013-01-29 | — | — | US | disclosed |
| US-8343928-B2 | Monomethylvaline compounds having phenylalanine side-chain replacements at the C-terminus | SEATTLE GENETICS, INC. (US) | 2013-01-01 | — | — | US | disclosed |
| US-20120238539-A1 | NOVEL PIPERAZINE ANALOGS AS BROAD-SPECTRUM INFLUENZA ANTIVIRALS | BRISTOL-MYERS SQUIBB COMPANY | 2012-09-20 | — | — | US | disclosed |
| WO-2012033736-A1 | NOVEL PIPERAZINE ANALOGS AS BROAD-SPECTRUM INFLUENZA ANTIVIRALS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2012-03-15 | — | — | WO | disclosed |
| WO-2010025856-A1 | SUBSTITUTED AMINOINDANES AND ANALOGS THEREOF, AND THE PHARMACEUTICAL USE THEREOF | SANOFI-AVENTIS (FR) | 2010-03-11 | — | — | WO | disclosed |
| US-20090111756-A1 | Monomethylvaline Compounds Having Phenylalanine Carboxy Modifications at the C-Terminus | SEATTLE GENECTICS, INC. (US) | 2009-04-30 | — | — | US | disclosed |
| US-20090018086-A1 | Monomethylvaline Compounds Having Phenylalanine Side-Chain Replacements at the C-Terminus | SEATTLE GENETICS, INC. (US) | 2009-01-15 | — | — | US | disclosed |
| EP-1126833-A4 | OXADIAZOLE, THIADIAZOLE AND TRIAZOLE DERIVATIVES AND COMBINATORIAL LIBRARIES THEREOF | TREGA BIOSCIENCES INC (US) | 2004-09-08 | — | — | EP | disclosed |
| EP-1126833-A2 | OXADIAZOLE, THIADIAZOLE AND TRIAZOLE DERIVATIVES AND COMBINATORIAL LIBRARIES THEREOF | TREGA BIOSCIENCES, INC. (US) | 2001-08-29 | — | — | EP | disclosed |
| WO-2000025768-A1 | OXADIAZOLE, THIADIAZOLE AND TRIAZOLE DERIVATIVES AND COMBINATORIAL LIBRARIES THEREOF | TREGA BIOSCIENCES, INC. (US) | 2000-05-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090111756-A1 | Monomethylvaline Compounds Having Phenylalanine Carboxy Modifications at the C-Terminus | MMAB, PTMS, CAD | CA12 1068/4885CA9 1847/4885CA1 1427/4885 |
| US-20120238539-A1 | NOVEL PIPERAZINE ANALOGS AS BROAD-SPECTRUM INFLUENZA ANTIVIRALS | ZC3HAV1, ZC3HAV1L, HCRTR1 | CA12 2976/4885CA9 3943/4885CA1 2804/4885 |
| US-20250326731-A1 | CATALYST-CONTROLLED SITE-SELECTIVE METHYLENE C-H LACTONIZATION OF DICARBOXYLIC ACIDS | DNPH1, NISCH, PTMA | CA12 427/4885CA9 2349/4885CA1 550/4885 |
| US-20090018086-A1 | Monomethylvaline Compounds Having Phenylalanine Side-Chain Replacements at the C-Terminus | MMAB, DNPEP, MARCKS | CA12 1527/4885CA9 2814/4885CA1 2340/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.